Global Fertility Services 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12247537

Publication Date:

December 24, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Fertility Services market size was valued at US$ 11160 million in 2023. With growing demand in downstream market, the Fertility Services is forecast to a readjusted size of US$ 18350 million by 2030 with a CAGR of 7.4% during review period.
The research report highlights the growth potential of the global Fertility Services market. Fertility Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Fertility Services. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Fertility Services market.
Fertility is the natural capability to produce offspring. As a measure, fertility rate is the number of offspring born per mating pair, individual or population. Fertility differs from fecundity, which is defined as the potential for reproduction (influenced by gamete production, fertilization and carrying a pregnancy to term). A lack of fertility is infertility while a lack of fecundity would be called sterility.
The underlying causes covered in the fertility services market report include male and female infertility. Among the two, female infertility is likely to be the dominant segment over the forecast period. Factors credited to the success of the segment include the prevalence of obesity, elapsed age of motherhood, endometrial tuberculosis, and other medical conditions.
Key Features:
The report on Fertility Services market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Fertility Services market. It may include historical data, market segmentation by Type (e.g., Infertility Drugs, Assisted Reproductive Technology (ART)), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Fertility Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Fertility Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Fertility Services industry. This include advancements in Fertility Services technology, Fertility Services new entrants, Fertility Services new investment, and other innovations that are shaping the future of Fertility Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Fertility Services market. It includes factors influencing customer ' purchasing decisions, preferences for Fertility Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Fertility Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Fertility Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Fertility Services market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Fertility Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Fertility Services market.
麻豆原创 Segmentation:
Fertility Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Infertility Drugs
Assisted Reproductive Technology (ART)
Segmentation by application
Male
Female
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck (Germany)
Cook Medical (U.S.)
Irvine Scientific (U.S.)
CooperSurgical (U.S.)
CARE Fertility Group (U.K.)
Ferring Pharmaceuticals (U.S.)
Vitrolife (U.S.)
Monash IVF Group (Australia)

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Fertility Services 麻豆原创 Size 2019-2030
2.1.2 Fertility Services 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Fertility Services Segment by Type
2.2.1 Infertility Drugs
2.2.2 Assisted Reproductive Technology (ART)
2.3 Fertility Services 麻豆原创 Size by Type
2.3.1 Fertility Services 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Fertility Services 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Fertility Services Segment by Application
2.4.1 Male
2.4.2 Female
2.5 Fertility Services 麻豆原创 Size by Application
2.5.1 Fertility Services 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Fertility Services 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Fertility Services 麻豆原创 Size by Player
3.1 Fertility Services 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Fertility Services Revenue by Players (2019-2024)
3.1.2 Global Fertility Services Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Fertility Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Fertility Services by Regions
4.1 Fertility Services 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Fertility Services 麻豆原创 Size Growth (2019-2024)
4.3 APAC Fertility Services 麻豆原创 Size Growth (2019-2024)
4.4 Europe Fertility Services 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Fertility Services 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Fertility Services 麻豆原创 Size by Country (2019-2024)
5.2 Americas Fertility Services 麻豆原创 Size by Type (2019-2024)
5.3 Americas Fertility Services 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fertility Services 麻豆原创 Size by Region (2019-2024)
6.2 APAC Fertility Services 麻豆原创 Size by Type (2019-2024)
6.3 APAC Fertility Services 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Fertility Services by Country (2019-2024)
7.2 Europe Fertility Services 麻豆原创 Size by Type (2019-2024)
7.3 Europe Fertility Services 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fertility Services by Region (2019-2024)
8.2 Middle East & Africa Fertility Services 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Fertility Services 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Fertility Services 麻豆原创 Forecast
10.1 Global Fertility Services Forecast by Regions (2025-2030)
10.1.1 Global Fertility Services Forecast by Regions (2025-2030)
10.1.2 Americas Fertility Services Forecast
10.1.3 APAC Fertility Services Forecast
10.1.4 Europe Fertility Services Forecast
10.1.5 Middle East & Africa Fertility Services Forecast
10.2 Americas Fertility Services Forecast by Country (2025-2030)
10.2.1 United States Fertility Services 麻豆原创 Forecast
10.2.2 Canada Fertility Services 麻豆原创 Forecast
10.2.3 Mexico Fertility Services 麻豆原创 Forecast
10.2.4 Brazil Fertility Services 麻豆原创 Forecast
10.3 APAC Fertility Services Forecast by Region (2025-2030)
10.3.1 China Fertility Services 麻豆原创 Forecast
10.3.2 Japan Fertility Services 麻豆原创 Forecast
10.3.3 Korea Fertility Services 麻豆原创 Forecast
10.3.4 Southeast Asia Fertility Services 麻豆原创 Forecast
10.3.5 India Fertility Services 麻豆原创 Forecast
10.3.6 Australia Fertility Services 麻豆原创 Forecast
10.4 Europe Fertility Services Forecast by Country (2025-2030)
10.4.1 Germany Fertility Services 麻豆原创 Forecast
10.4.2 France Fertility Services 麻豆原创 Forecast
10.4.3 UK Fertility Services 麻豆原创 Forecast
10.4.4 Italy Fertility Services 麻豆原创 Forecast
10.4.5 Russia Fertility Services 麻豆原创 Forecast
10.5 Middle East & Africa Fertility Services Forecast by Region (2025-2030)
10.5.1 Egypt Fertility Services 麻豆原创 Forecast
10.5.2 South Africa Fertility Services 麻豆原创 Forecast
10.5.3 Israel Fertility Services 麻豆原创 Forecast
10.5.4 Turkey Fertility Services 麻豆原创 Forecast
10.5.5 GCC Countries Fertility Services 麻豆原创 Forecast
10.6 Global Fertility Services Forecast by Type (2025-2030)
10.7 Global Fertility Services Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Merck (Germany)
11.1.1 Merck (Germany) Company Information
11.1.2 Merck (Germany) Fertility Services Product Offered
11.1.3 Merck (Germany) Fertility Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Merck (Germany) Main Business Overview
11.1.5 Merck (Germany) Latest Developments
11.2 Cook Medical (U.S.)
11.2.1 Cook Medical (U.S.) Company Information
11.2.2 Cook Medical (U.S.) Fertility Services Product Offered
11.2.3 Cook Medical (U.S.) Fertility Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Cook Medical (U.S.) Main Business Overview
11.2.5 Cook Medical (U.S.) Latest Developments
11.3 Irvine Scientific (U.S.)
11.3.1 Irvine Scientific (U.S.) Company Information
11.3.2 Irvine Scientific (U.S.) Fertility Services Product Offered
11.3.3 Irvine Scientific (U.S.) Fertility Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Irvine Scientific (U.S.) Main Business Overview
11.3.5 Irvine Scientific (U.S.) Latest Developments
11.4 CooperSurgical (U.S.)
11.4.1 CooperSurgical (U.S.) Company Information
11.4.2 CooperSurgical (U.S.) Fertility Services Product Offered
11.4.3 CooperSurgical (U.S.) Fertility Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 CooperSurgical (U.S.) Main Business Overview
11.4.5 CooperSurgical (U.S.) Latest Developments
11.5 CARE Fertility Group (U.K.)
11.5.1 CARE Fertility Group (U.K.) Company Information
11.5.2 CARE Fertility Group (U.K.) Fertility Services Product Offered
11.5.3 CARE Fertility Group (U.K.) Fertility Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 CARE Fertility Group (U.K.) Main Business Overview
11.5.5 CARE Fertility Group (U.K.) Latest Developments
11.6 Ferring Pharmaceuticals (U.S.)
11.6.1 Ferring Pharmaceuticals (U.S.) Company Information
11.6.2 Ferring Pharmaceuticals (U.S.) Fertility Services Product Offered
11.6.3 Ferring Pharmaceuticals (U.S.) Fertility Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Ferring Pharmaceuticals (U.S.) Main Business Overview
11.6.5 Ferring Pharmaceuticals (U.S.) Latest Developments
11.7 Vitrolife (U.S.)
11.7.1 Vitrolife (U.S.) Company Information
11.7.2 Vitrolife (U.S.) Fertility Services Product Offered
11.7.3 Vitrolife (U.S.) Fertility Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Vitrolife (U.S.) Main Business Overview
11.7.5 Vitrolife (U.S.) Latest Developments
11.8 Monash IVF Group (Australia)
11.8.1 Monash IVF Group (Australia) Company Information
11.8.2 Monash IVF Group (Australia) Fertility Services Product Offered
11.8.3 Monash IVF Group (Australia) Fertility Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Monash IVF Group (Australia) Main Business Overview
11.8.5 Monash IVF Group (Australia) Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.